Bn cnh s dng L-glutathione, ngi bnh iu tr kt hp vi cc liu php khc nh ha tr, x tr v phu thut
S kt hp gia glutathione v cc thnh phn khc trong vin ung gip tng cng hiu qu lm p mt cch ton din
Validated the recovery rate by measuring both free drug and total drug (after lysis with Triton X-100) to ensure mass balance
93,94,95,96 Advancements in carrier technology and nucleic acid modification techniques have led to significant progress in overcoming these challenges, as exemplified by the first siRNA drug, patisiran (Onpattro), which has been approved for treating hereditary transthyretin-mediated amyloidosis by degrading mRNA encoding transthyretin (TTR)
Biomarker data used are serum AST and ALT
Additionally, separate locations were used for treatment administration and data collection to minimize the risk of unblinding